Interestingly, high TFCP2 expression (p = 0.049) and low SULF1 expression (p = 0.039) significantly correlated with poorer overall survival outcomes for patients with skin cutaneous melanoma (Fig. 5, F and G). The gene discussed is TFCP2; the disease is cutaneous melanoma.